About the Study
How do we encourage advancement in the global standard for quality management maturity that improves production efficiency?
Through active participation across the global pharmaceutical manufacturing community, we can collaborate to produce a knowledge base that characterizes the state of quality management practices.
In addition, you will learn how your establishment’s quality management practices compare to global baselines. Participating in this study will provide you with insights about your quality management maturity with specific details on key performance indicators and attributes of your quality culture. Your customized report will clearly identify opportunities for your continual improvement.
The study will close on October 30, 2020. See our list of frequently asked questions.
Dun & Bradstreet’s data and analytics capabilities deliver an unmatched base of knowledge about global manufacturers, but our partners bring the study to life. The University of St.Gallen in Switzerland is the authority on Operational Excellence research in the fields of pharmaceutical, over-the-counter, and personal care manufacturing.
This study is funded by the U.S. Food and Drug Administration.
Participate and Get a Free Report
Your participation in the Quality Benchmarking Study is essential. Characterizing a representative global baseline requires participation of establishments from a spectrum of product types, geographic regions, establishment sizes, quality management practices, and other corporate attributes. Participation is simple and can be conducted online, by phone, or in-person at your establishment. All questionnaire response data will be anonymized prior to any use or review by the U.S. Food and Drug Administration.